Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib treatment for hair loss may worsen acne.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Upadacitinib may effectively treat alopecia areata without side effects.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tofacitinib treatment is used for teenagers with alopecia areata.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.